These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10928292)

  • 21. Development of hypertension in a pyelonephritis-induced model: the effect of salt intake and inability of renal sodium handling.
    de Magalhães Sartim R; Fantinato Menegon L; de Almeida AR; Rocha Gontijo JA; Aline Boer P
    Ren Fail; 2006; 28(6):501-7. PubMed ID: 16928620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin resistance and low urinary citrate excretion in calcium stone formers.
    Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
    Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of nutrient profiles of the Dietary Approaches to Stop Hypertension (DASH) diets on blood pressure and bone metabolism and composition in normotensive and hypertensive rats.
    Doyle L; Cashman KD
    Br J Nutr; 2003 May; 89(5):713-24. PubMed ID: 12720595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction of blood pressure with calcium and potassium supplementation in children with salt sensitivity: a 2-year double-blinded placebo-controlled trial.
    Mu JJ; Liu ZQ; Liu WM; Liang YM; Yang DY; Zhu DJ; Wang ZX
    J Hum Hypertens; 2005 Jun; 19(6):479-83. PubMed ID: 15759021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypertension, calcium metabolism, and nephrolithiasis.
    Strazzullo P; Mancini M
    Am J Med Sci; 1994 Feb; 307 Suppl 1():S102-6. PubMed ID: 8141146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal stone risk in a simulated microgravity environment: impact of treadmill exercise with lower body negative pressure.
    Monga M; Macias B; Groppo E; Kostelec M; Hargens A
    J Urol; 2006 Jul; 176(1):127-31. PubMed ID: 16753386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in urine volume accomplished by physicians treating nephrolithiasis.
    Parks JH; Goldfischer ER; Coe FL
    J Urol; 2003 Mar; 169(3):863-6. PubMed ID: 12576800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potassium: more beneficial effects.
    He FJ; MacGregor GA
    Climacteric; 2003 Oct; 6 Suppl 3():36-48. PubMed ID: 15018247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of sodium chloride on bone health].
    Sarić M; Piasek M
    Arh Hig Rada Toksikol; 2005 Mar; 56(1):39-44. PubMed ID: 15969207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Alterations in bone mineral metabolism in patients with calcium kidney stone disease and polymorphism of vitamin D receptor. Preliminary results].
    Moyano MJ; Gómez de Tejada MJ; García Lozano R; Moruno R; Ortega R; Martí V; Sánchez Palencia R; Miranda MJ; Palma A; Pérez Cano R
    Nefrologia; 2007; 27(6):694-703. PubMed ID: 18336098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dietary protein and bone health.
    Ginty F
    Proc Nutr Soc; 2003 Nov; 62(4):867-76. PubMed ID: 15018487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salt and blood pressure: population and individual perspectives.
    Kuller LH
    Am J Hypertens; 1997 May; 10(5 Pt 2):29S-36S. PubMed ID: 9160777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions.
    Pak CY; Heller HJ; Pearle MS; Odvina CV; Poindexter JR; Peterson RD
    J Urol; 2003 Feb; 169(2):465-9. PubMed ID: 12544288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Osteoporosis and alcohol intake].
    Kogawa M; Wada S
    Clin Calcium; 2005 Jan; 15(1):102-5. PubMed ID: 15632479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased calcium excretion after saline administration to hypertensive subjects.
    Ackerman GL
    J Lab Clin Med; 1971 Feb; 77(2):298-306. PubMed ID: 5540773
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of intravenous sodium chloride on renal sodium and calcium handling in hypertensive patients with different sensitivities to sodium chloride.
    Galletti F; Ferrara I; Stinga F; Sacchi A; Barba G; Iacone R; Strazzullo P
    J Hypertens Suppl; 1993 Dec; 11(5):S194-5. PubMed ID: 8158339
    [No Abstract]   [Full Text] [Related]  

  • 39. The myth of long-term thiazide-induced magnesium deficiency.
    Cohen L; Kitzes R; Shnaider H
    Magnesium; 1985; 4(4):176-81. PubMed ID: 4079463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salt--more adverse effects.
    MacGregor GA
    Am J Hypertens; 1997 May; 10(5 Pt 2):37S-41S. PubMed ID: 9160778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.